Insider Transactions Reported by 24 Insiders of Neurogene Inc.

Symbol
NGNE on Nasdaq
Location
New York, NY

Insiders trading volume in the past year

Neurogene Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Samsara BioCapital GP, LLC 10%+ Owner $47,220,993 26 Nov 2024
Rachel McMinn Chief Executive Officer, Director $25,457,278 20 Feb 2026
Christine Mikail President and CFO $2,165,606 -$76,247 -3.4% 20 Feb 2026
Stuart Cobb Chief Scientific Officer $704,483 -$103,003 -13% 20 Feb 2026
BAKER BROS. ADVISORS LP Director, Former 10% Owner $287,276 18 Dec 2023
Julie Jordan Chief Medical Officer $251,237 20 Feb 2026
Priti Patel Former Chief Medical Officer $25,850 31 Mar 2023
Sean Smith Interim CFO, Prin Acct Off $14,990 10 Aug 2023
JONATHAN G. DRACHMAN President and CEO, Director 02 Aug 2022
Robert Ho Chief Financial Officer 01 Feb 2022
Holly Vance General Counsel 03 Aug 2021
Donna Cochener General Counsel, SVP Legal 02 Aug 2022
Erin Lavelle Director 08 Jun 2023
Erin M. Lavelle Director 11 May 2021
Martin Babler Director 08 Jun 2023
Carl Walkey Senior Vice President 02 Aug 2022
Lewis T. Williams Director 11 May 2021
TODD E. SIMPSON Director 08 Jun 2023
Cory S. Freedland Director 20 Feb 2026
ROBERT BAFFI Director 20 Feb 2026
Robert Keith Woods Director 12 Jun 2025
Sarah B. Noonberg Director 20 Feb 2026
ROHAN PALEKAR Director 20 Feb 2026
Keith Woods Director 20 Feb 2026

Recent Insider Transactions by Companies or Individuals for Neurogene Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.